Has Jane Curl, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,358 in general payments to Jane Curl, MD across 25 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jane Curl, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jane Curl, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jane Curl, MD

Pulmonary Disease · Hopedale, MANPI 1316964281

Payments from drug & device makers

$2,358in general payments, 2019–2025

Across 25 payments — averaging $94.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inspire Medical Systems, Inc.$2K
AstraZeneca$55
Sanofi$49
Pfizer$26

What the payments were for

Travel & lodging$1,59668%
Food & beverage$76132%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inspire Medical Systems, Inc.	20	$2,227
AstraZeneca	2	$55
Sanofi	2	$49
Pfizer	1	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Inspire$1,694

How this compares

$2,358 in reported general payments places this provider in the 65th percentile of 482 pulmonary disease providers in Massachusetts.

See all pulmonary disease providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$207,969

Medicare patients

613

Services billed

1,487

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	253	$203,491
Prolastin CAlpha-1-Proteinase Inhibitor	12	$138,149
Dupixent PenDupilumab	13	$49,708
Breo ElliptaFluticasone/Vilanterol	101	$45,570
Spiriva RespimatTiotropium Bromide	22	$13,640
Arnuity ElliptaFluticasone Furoate	41	$12,949
Incruse ElliptaUmeclidinium Bromide	28	$12,432
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr	26	$12,007
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate	23	$9,172
Spiriva HandihalerTiotropium Bromide	11	$5,404
Ventolin HfaAlbuterol Sulfate	60	$4,850
Albuterol Sulfate HfaAlbuterol Sulfate	133	$4,790
Roflumilast	20	$3,984
Wixela InhubFluticasone Propion/Salmeterol	16	$2,340
Ramelteon	20	$2,298

Paid to pharmacies, not to this prescriber.

Other pulmonary disease in Hopedale

Aaron WaxmanBoston$7.7M
John BerkBoston$6M
Darrell KottonBoston$5.3M
Hilary GoldbergBoston$3.5M
Ehab BillatosWinchester$2.7M
Harrison FarberBoston$2.6M
Elizabeth KlingsBoston$2.1M
Curtis MelloNorth Dartmouth$1.9M
Gary HunninghakeBoston$1.5M
Elliot IsraelBrookline$1.4M

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →